Brain Dysfunction in Genetically Determined Accelerated Aging Syndromes.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Human progeroid syndromes, rare genetic disorders caused by single-gene mutations, provide insights into brain development, aging, and neurodegeneration.
• The precise relationship between these mutations and neurological outcomes is not fully understood.
• Existing research often lacks translational relevance due to limitations in animal models.

Purpose of the Study:

• To synthesize diverse data (clinical, neuroimaging, cognitive, experimental) on progeroid syndromes.
• To propose a framework linking genetic mutations to neurological phenotypes.
• To highlight the need for improved, human-relevant models for studying brain aging in genetic disorders.

Main Methods:

• Integrative translational review of clinical, neuroimaging, cognitive, and experimental data.
• Analysis of genetic mutations in DNA repair disorders, RecQ helicase-associated syndromes, and laminopathies.
• Evaluation of existing animal models for their translational utility.

Main Results:

• A working hypothesis suggests primary neurodegeneration is most consistent when mutant genes are expressed in post-mitotic neurons.
• Neurological phenotypes can arise secondarily from glial dysfunction, vascular pathology, or systemic disease.
• Neuron-specific mechanisms, like miR-9 silencing, can decouple systemic and brain aging.

Conclusions:

• Genetic mutations in progeroid syndromes impact brain aging through direct neuronal effects, secondary pathologies, and protective mechanisms.
• Understanding these complex interactions is crucial for developing effective monitoring and therapeutic strategies.
• Future research must prioritize human-relevant models to accurately study gene mutation effects on brain dysfunction and aging.